Free Trial

MarketBeat Instant News Alerts

Lululemon Athletica logo with Consumer Discretionary background

Lululemon Athletica (NASDAQ:LULU) Given New $346.00 Price Target at Morgan Stanley

MarketBeat

Morgan Stanley cut their price objective on Lululemon Athletica from $373.00 to $346.00 and set an "overweight" rating for the company in a research report on Wednesday.

NASDAQ:LULU
Read Lululemon Athletica (NASDAQ:LULU) Given New $346.00 Price Target at Morgan Stanley
E2open Parent logo with Computer and Technology background

E2open Parent (NYSE:ETWO) Given New $3.30 Price Target at Morgan Stanley

MarketBeat

Morgan Stanley upped their price target on E2open Parent from $2.10 to $3.30 and gave the stock an "equal weight" rating in a research report on Wednesday.

NYSE:ETWO
Read E2open Parent (NYSE:ETWO) Given New $3.30 Price Target at Morgan Stanley
Jones Lang LaSalle logo with Finance background

Citigroup Cuts Jones Lang LaSalle (NYSE:JLL) Price Target to $240.00

MarketBeat

Citigroup decreased their price objective on shares of Jones Lang LaSalle from $275.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday.

NYSE:JLL
Read Citigroup Cuts Jones Lang LaSalle (NYSE:JLL) Price Target to $240.00
Invivyd logo with Medical background

Invivyd (NASDAQ:IVVD) Price Target Cut to $5.00 by Analysts at HC Wainwright

MarketBeat

HC Wainwright decreased their price objective on Invivyd from $10.00 to $5.00 and set a "buy" rating for the company in a research report on Wednesday.

NASDAQ:IVVD
Read Invivyd (NASDAQ:IVVD) Price Target Cut to $5.00 by Analysts at HC Wainwright
Cytek Biosciences logo with Medical background

Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock Price

MarketBeat

Morgan Stanley lowered their price target on Cytek Biosciences from $9.00 to $7.00 and set an "equal weight" rating for the company in a report on Wednesday.

NASDAQ:CTKB
Read Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock Price
BOX logo with Computer and Technology background

Morgan Stanley Forecasts Strong Price Appreciation for BOX (NYSE:BOX) Stock

MarketBeat

Morgan Stanley increased their price target on shares of BOX from $35.00 to $38.00 and gave the company an "equal weight" rating in a report on Wednesday.

NYSE:BOX
Read Morgan Stanley Forecasts Strong Price Appreciation for BOX (NYSE:BOX) Stock

Trending News

All MarketBeat Instant News Alerts

Eagle Materials logo with Construction background

Citigroup Issues Pessimistic Forecast for Eagle Materials (NYSE:EXP) Stock Price

MarketBeat
NYSE:EXP
Read Citigroup Issues Pessimistic Forecast for Eagle Materials (NYSE:EXP) Stock Price
AutoZone logo with Retail/Wholesale background

AutoZone's (AZO) "Overweight" Rating Reiterated at Morgan Stanley

MarketBeat
NYSE:AZO
Read AutoZone's (AZO) "Overweight" Rating Reiterated at Morgan Stanley
Westlake logo with Basic Materials background

Westlake (NYSE:WLK) Receives "Buy" Rating from Citigroup

MarketBeat
NYSE:WLK
Read Westlake (NYSE:WLK) Receives "Buy" Rating from Citigroup
Savara logo with Medical background

Evercore ISI Lowers Savara (NASDAQ:SVRA) Price Target to $2.00

MarketBeat
NASDAQ:SVRA
Read Evercore ISI Lowers Savara (NASDAQ:SVRA) Price Target to $2.00
Liberty Global logo with Computer and Technology background

Liberty Global (NASDAQ:LBTYA) Given New $11.00 Price Target at Citigroup

MarketBeat
NASDAQ:LBTYA
Read Liberty Global (NASDAQ:LBTYA) Given New $11.00 Price Target at Citigroup
Okta logo with Computer and Technology background

Okta (NASDAQ:OKTA) Given New $130.00 Price Target at Evercore ISI

MarketBeat
NASDAQ:OKTA
Read Okta (NASDAQ:OKTA) Given New $130.00 Price Target at Evercore ISI
CarMax logo with Retail/Wholesale background

CarMax (NYSE:KMX) Price Target Lowered to $84.00 at Evercore ISI

MarketBeat
NYSE:KMX
Read CarMax (NYSE:KMX) Price Target Lowered to $84.00 at Evercore ISI
Banco Bradesco logo with Finance background

Banco Bradesco (NYSE:BBD) Raised to Buy at Citigroup

MarketBeat
NYSE:BBD
Read Banco Bradesco (NYSE:BBD) Raised to Buy at Citigroup
Semtech logo with Computer and Technology background

Semtech's (SMTC) Buy Rating Reaffirmed at Benchmark

MarketBeat
NASDAQ:SMTC
Read Semtech's (SMTC) Buy Rating Reaffirmed at Benchmark
Five Below logo with Retail/Wholesale background

Evercore ISI Forecasts Strong Price Appreciation for Five Below (NASDAQ:FIVE) Stock

MarketBeat
NASDAQ:FIVE
Read Evercore ISI Forecasts Strong Price Appreciation for Five Below (NASDAQ:FIVE) Stock
Boston Scientific logo with Medical background

Needham & Company LLC Reiterates "Buy" Rating for Boston Scientific (NYSE:BSX)

MarketBeat
NYSE:BSX
Read Needham & Company LLC Reiterates "Buy" Rating for Boston Scientific (NYSE:BSX)
ZEEKR Intelligent Technology logo with Auto/Tires/Trucks background

ZEEKR Intelligent Technology (NYSE:ZK) Price Target Lowered to $38.00 at Macquarie

MarketBeat
NYSE:ZK
Read ZEEKR Intelligent Technology (NYSE:ZK) Price Target Lowered to $38.00 at Macquarie
Privia Health Group logo with Medical background

Privia Health Group (NASDAQ:PRVA) Price Target Raised to $32.00

MarketBeat
NASDAQ:PRVA
Read Privia Health Group (NASDAQ:PRVA) Price Target Raised to $32.00
BOX logo with Computer and Technology background

JPMorgan Chase & Co. Forecasts Strong Price Appreciation for BOX (NYSE:BOX) Stock

MarketBeat
NYSE:BOX
Read JPMorgan Chase & Co. Forecasts Strong Price Appreciation for BOX (NYSE:BOX) Stock
Moog logo with Aerospace background

Moog (NYSE:MOG.B) Trading Up 9.8% - Here's Why

MarketBeat
NYSE:MOG.B
Read Moog (NYSE:MOG.B) Trading Up 9.8% - Here's Why
Equity Residential logo with Finance background

MarketBeat
NYSE:EQR
Read
Y-mAbs Therapeutics logo with Medical background

Wedbush Reiterates Outperform Rating for Y-mAbs Therapeutics (NASDAQ:YMAB)

MarketBeat
NASDAQ:YMAB
Read Wedbush Reiterates Outperform Rating for Y-mAbs Therapeutics (NASDAQ:YMAB)
Y-mAbs Therapeutics logo with Medical background

Wedbush Reaffirms "Outperform" Rating for Y-mAbs Therapeutics (NASDAQ:YMAB)

MarketBeat
NASDAQ:YMAB
Read Wedbush Reaffirms "Outperform" Rating for Y-mAbs Therapeutics (NASDAQ:YMAB)
AMC Entertainment logo with Consumer Discretionary background

AMC Entertainment (NYSE:AMC) Sees Unusually-High Trading Volume - Here's Why

MarketBeat
NYSE:AMC
Read AMC Entertainment (NYSE:AMC) Sees Unusually-High Trading Volume - Here's Why
Grupo Supervielle logo with Finance background

Grupo Supervielle (NYSE:SUPV) Sees Large Volume Increase - Should You Buy?

MarketBeat
NYSE:SUPV
Read Grupo Supervielle (NYSE:SUPV) Sees Large Volume Increase - Should You Buy?
IDACORP logo with Utilities background

IDACORP (NYSE:IDA) Sees Large Volume Increase - Time to Buy?

MarketBeat
NYSE:IDA
Read IDACORP (NYSE:IDA) Sees Large Volume Increase - Time to Buy?
Metals Acquisition logo with Basic Materials background

Metals Acquisition (NYSE:MTAL) Sees Unusually-High Trading Volume - Should You Buy?

MarketBeat
NYSE:MTAL
Read Metals Acquisition (NYSE:MTAL) Sees Unusually-High Trading Volume - Should You Buy?
Gyre Therapeutics logo with Medical background

Gyre Therapeutics (NASDAQ:GYRE) Sees Strong Trading Volume - Should You Buy?

MarketBeat
NASDAQ:GYRE
Read Gyre Therapeutics (NASDAQ:GYRE) Sees Strong Trading Volume - Should You Buy?
Biglari logo with Retail/Wholesale background

Biglari (NYSE:BH.A) Sees Large Volume Increase - Should You Buy?

MarketBeat
NYSE:BH.A
Read Biglari (NYSE:BH.A) Sees Large Volume Increase - Should You Buy?

Featured Articles and Offers

Sector News